Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital

By Reuters News

- FRESENIUS SE & CO. KGAA FREn.DE:

  • COMPLETES SALE OF 13.4 MILLION FRESENIUS MEDICAL CARE SHARES AT €39.00 PER SHARE, RAISING APPROXIMATELY €524 MILLION

  • SETTLEMENT IS EXPECTED ON 16 NOVEMBER 2026

  • ANTICIPATED BOOK GAIN IN LOW TO MID DOUBLE-DIGIT MILLION EURO RANGE WILL BE REFLECTED IN Q4 2026 RESULTS

  • REMAINS SUBJECT TO A LOCK-UP ON ITS REMAINING SHARES OF 90 DAYS

  • PROCEEDS WILL BE USED CONSISTENTLY WITH STATED CAPITAL ALLOCATION PRIORITIES SET OUT UNDER #FUTUREFRESENIUS

  • FINANCIAL INVESTMENT IN FRESENIUS MEDICAL CARE REDUCES FROM APPROXIMATELY 25 PER CENT TO APPROXIMATELY 20 PER CENT OF ISSUED SHARE CAPITAL

Further company coverage: [FREn.DE]

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.